6336-34-1

Usage

Uses

Used in Pharmaceutical Research and Drug Development:
4-(4-carbamoylphenoxy)benzamide is utilized as a chemical entity in the discovery and development of new pharmaceuticals. Its unique structure and potential biological activities make it a candidate for further investigation into its therapeutic potential.
Used in Biological Activity Studies:
In the field of biological research, 4-(4-carbamoylphenoxy)benzamide is used as a subject of study to explore its interactions with biological systems. This research aims to uncover its possible roles in various biological processes and its efficacy as a therapeutic agent.
Note: Since the provided materials do not specify particular applications or industries for 4-(4-carbamoylphenoxy)benzamide, the uses listed are general and based on the potential inferred from its description as a compound with potential biological activities. Further research would be necessary to identify specific applications in various industries.

Upstream product

• 7158-32-9 4,4'-bis(chlorocarbonyl)diphenyl oxide 
• 2215-89-6 oxybis(benzoic acid) 
• 623-00-7 4-bromobenzenecarbonitrile 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 2215-76-1 4-(4-formylphenoxy)benzaldehyde 
• 101-84-8 diphenylether 

Downstream Products

• 2579-42-2 4,4'-oxy-bis-benzylamine; dihydrochloride 
• 2215-89-6 oxybis(benzoic acid) 

Relevant academic research and scientific papers

Design, synthesis and evaluation of potent and selective inhibitors of mono-(ADP-ribosyl)transferases PARP10 and PARP14

A series of diaryl ethers were designed and synthesized to discern the structure activity relationships against the two closely related mono-(ADP-ribosyl)transferases PARP10 and PARP14. Structure activity studies identified 8b as a sub-micromolar inhibito

Rational Design of Cell-Active Inhibitors of PARP10

Poly-ADP-ribose polymerases (PARPs 1-16) have emerged as major regulators of diverse cellular processes. PARPs can be subclassified based on their ability to catalyze poly-ADP-ribosylation (PARylation) or mono-ADP-ribosylation (MARylation). While much is

An artificial receptor for the intermolecular and enantioselective formation of peptide sheets

Peptide strands coupled at the C terminus to bis[p(aminomethyl)phenyl] ether allow in CHCl3 solution association of lipophilic N-protected peptides with hydrogen bonds in the mode of antiparallel β-sheets; the enantioselectivity observed with a phenylalanine derivative is characterized by a binding constant ratio of around 15.